1
|
Zhu Y, Li F, Wang S, Shi H, Zhao M, You S, Su S, Cheng G. Composite Polysaccharide Hydrogel Loaded with Scutellaria baicalensis Extract for Diabetic Wound Treatment. Gels 2024; 10:605. [PMID: 39330207 PMCID: PMC11431221 DOI: 10.3390/gels10090605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2024] [Revised: 09/10/2024] [Accepted: 09/17/2024] [Indexed: 09/28/2024] Open
Abstract
Diabetic wounds present significant burdens to both patients and the healthcare system due to their prolonged inflammatory phase and adverse microenvironment. Traditional Chinese medicine (TCM), particularly Scutellaria baicalensis extract (SE), has shown promise in wound healing. Herein, sesbania gum (SG) was oxidized and formed hydrogel with carboxymethyl chitosan (CMCS) through the imine bond. Then, SE was loaded into the hydrogel as a wound dressing (CMCS-OSG@SE hydrogel). In vitro experiments demonstrated the mechanical properties and ROS scavenging efficiency of the hydrogel, as well as the release of SE and its biocompatibility. In an vivo study, diabetic mice with S. aureus infection were used, and the CMCS--OSG@SE hydrogel dressing accelerated wound healing by promoting epidermal regeneration and collagen deposition. This composite polysaccharide hydrogel loaded with SE shows great potential for diabetic wound treatment.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Gang Cheng
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103 Wenhua Road, Shenyang 110016, China; (Y.Z.); (F.L.); (S.W.); (H.S.); (M.Z.); (S.Y.); (S.S.)
| |
Collapse
|
2
|
Guo J, Wang P, Li Y, Liu Y, Ye Y, Chen Y, Kankala RK, Tong F. Advances in hybridized nanoarchitectures for improved oro-dental health. J Nanobiotechnology 2024; 22:469. [PMID: 39113060 PMCID: PMC11305065 DOI: 10.1186/s12951-024-02680-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2024] [Accepted: 07/01/2024] [Indexed: 08/11/2024] Open
Abstract
On a global note, oral health plays a critical role in improving the overall human health. In this vein, dental-related issues with dentin exposure often facilitate the risk of developing various oral-related diseases in gums and teeth. Several oral-based ailments include gums-associated (gingivitis or periodontitis), tooth-based (dental caries, root infection, enamel erosion, and edentulous or total tooth loss), as well as miscellaneous diseases in the buccal or oral cavity (bad breath, mouth sores, and oral cancer). Although established conventional treatment modalities have been available to improve oral health, these therapeutic options suffer from several limitations, such as fail to eradicate bacterial biofilms, deprived regeneration of dental pulp cells, and poor remineralization of teeth, resulting in dental emergencies. To this end, the advent of nanotechnology has resulted in the development of various innovative nanoarchitectured composites from diverse sources. This review presents a comprehensive overview of different nanoarchitectured composites for improving overall oral health. Initially, we emphasize various oral-related diseases, providing detailed pathological circumstances and their effects on human health along with deficiencies of the conventional therapeutic modalities. Further, the importance of various nanostructured components is emphasized, highlighting their predominant actions in solving crucial dental issues, such as anti-bacterial, remineralization, and tissue regeneration abilities. In addition to an emphasis on the synthesis of different nanostructures, various nano-therapeutic solutions from diverse sources are discussed, including natural (plant, animal, and marine)-based components and other synthetic (organic- and inorganic-) architectures, as well as their composites for improving oral health. Finally, we summarize the article with an interesting outlook on overcoming the challenges of translating these innovative platforms to clinics.
Collapse
Affiliation(s)
- Jun Guo
- School of Stomatology, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
- Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, 330006, People's Republic of China.
- Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, 330006, People's Republic of China.
| | - Pei Wang
- School of Stomatology, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, 330006, People's Republic of China
- Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, 330006, People's Republic of China
| | - Yuyao Li
- School of Stomatology, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, 330006, People's Republic of China
- Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, 330006, People's Republic of China
| | - Yifan Liu
- School of Stomatology, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, 330006, People's Republic of China
- Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, 330006, People's Republic of China
| | - Yingtong Ye
- Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, 361021, People's Republic of China
| | - Yi Chen
- School of Stomatology, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China
- Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, 330006, People's Republic of China
- Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, 330006, People's Republic of China
| | - Ranjith Kumar Kankala
- Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, 361021, People's Republic of China.
| | - Fei Tong
- School of Stomatology, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
- Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, 330006, People's Republic of China.
- Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, 330006, People's Republic of China.
| |
Collapse
|
3
|
Li J, Lin M, Xie Z, Chen L, Qi J, Yu B. Target Cell Extraction and Spectrum-Effect Relationship Coupled with BP Neural Network Classification for Screening Potential Bioactive Components in Ginseng Extract with a Protective Effect against Myocardial Damage. Molecules 2024; 29:2028. [PMID: 38731522 PMCID: PMC11085743 DOI: 10.3390/molecules29092028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2024] [Revised: 04/10/2024] [Accepted: 04/19/2024] [Indexed: 05/13/2024] Open
Abstract
Cardiovascular disease has become a common ailment that endangers human health, having garnered widespread attention due to its high prevalence, recurrence rate, and sudden death risk. Ginseng possesses functions such as invigorating vital energy, enhancing vein recovery, promoting body fluid and blood nourishment, calming the nerves, and improving cognitive function. It is widely utilized in the treatment of various heart conditions, including palpitations, chest pain, heart failure, and other ailments. Although numerous research reports have investigated the cardiovascular activity of single ginsenoside, there remains a lack of systematic research on the specific components group that predominantly contribute to cardiovascular efficacy in ginseng medicinal materials. In this research, the spectrum-effect relationship, target cell extraction, and BP neural network classification were used to establish a rapid screening system for potential active substances. The results show that red ginseng extract (RGE) can improve the decrease in cell viability and ATP content and inhibit the increase in ROS production and LDH release in OGD-induced H9c2 cells. A total of 70 ginsenosides were identified in RGE using HPLC-Q-TOF-MS/MS analysis. Chromatographic fingerprints were established for 12 batches of RGE by high-performance liquid chromatography (HPLC). A total of 36 common ingredients were found in 12 batches of RGE. The cell viability, ATP, ROS, and LDH of 12 batches RGE were tested to establish gray relationship analysis (GRA) and partial least squares discrimination analysis (PLS-DA). BP neural network classification and target cell extraction were used to narrow down the scope of Spectral efficiency analysis and screen the potential active components. According to the cell experiments, RGE can improve the cell viability and ATP content and reduce the oxidative damage. Then, seven active ingredients, namely, Ginsenoside Rg1, Rg2, Rg3, Rb1, Rd, Re, and Ro, were screened out, and their cardiovascular activity was confirmed in the OGD model. The seven ginsenosides were the main active substances of red ginseng in treating myocardial injury. This study offers a reference for quality control in red ginseng and preparations containing red ginseng for the management of cardiovascular diseases. It also provides ideas for screening active ingredients of the same type of multi-pharmacologically active traditional Chinese medicines.
Collapse
Affiliation(s)
- Junyi Li
- Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; (J.L.); (M.L.); (Z.X.); (L.C.)
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Min Lin
- Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; (J.L.); (M.L.); (Z.X.); (L.C.)
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Zexin Xie
- Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; (J.L.); (M.L.); (Z.X.); (L.C.)
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Liwenyu Chen
- Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; (J.L.); (M.L.); (Z.X.); (L.C.)
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Jin Qi
- Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; (J.L.); (M.L.); (Z.X.); (L.C.)
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Boyang Yu
- Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China; (J.L.); (M.L.); (Z.X.); (L.C.)
- Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| |
Collapse
|
4
|
Zhou P, Zuo L, Liu C, Xiong B, Li Z, Zhou X, Yue H, Jia Q, Zheng T, Zou J, Du S, Chen D, Sun Z. Unraveling spatial metabolome of the aerial and underground parts of Scutellaria baicalensis by matrix-assisted laser desorption/ionization mass spectrometry imaging. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2024; 123:155259. [PMID: 38096718 DOI: 10.1016/j.phymed.2023.155259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 11/20/2023] [Accepted: 12/04/2023] [Indexed: 01/17/2024]
Abstract
BACKGROUND Scutellaria baicalensis Georgi, a traditional Chinese medicine, is clinically applied mainly as the dried root of Scutellaria baicalensis, and the aerial parts of Scutellaria baicalensis, its stems and leaves, are often consumed as "Scutellaria baicalensis tea" to clear heat, dry dampness, reduce fire and detoxify, while few comparative analyses of the spatial metabolome of the aerial and underground parts of Scutellaria baicalensis have been carried out in current research. METHODS In this work, Matrix-assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI) was used to visualize the spatial imaging of the root, stem, and leaf of Scutellaria baicalensis at a high resolution of 10 μm, respectively, investigating the spatial distribution of the different secondary metabolites in the aerial and underground parts of Scutellaria baicalensis. RESULTS In the present results, various metabolites, such as flavonoid glycosides, flavonoid metabolites, and phenolic acids, were systematically characterized in Scutellaria baicalensis root, stem, and leaf. Nine glycosides, 18 flavonoids, one organic acid, and four other metabolites in Scutellaria baicalensis root; nine glycosides, nine flavonoids, one organic acid in Scutellaria baicalensis stem; and seven flavonoids and seven glycosides in Scutellaria baicalensis leaf were visualized by MALDI-MSI. In the underground part of Scutellaria baicalensis, baicalein, wogonin, baicalin, wogonoside, and chrysin were widely distributed, while there was less spatial location in the aerial parts. Moreover, scutellarein, carthamidin/isocarthamidin, scutellarin, carthamidin/isocarthamidin-7-O-glucuronide had a high distribution in the aerial parts of Scutellaria baicalensis. In addition, the biosynthetic pathways involved in the biosynthesis of significant flavonoid metabolites in aerial and underground parts of Scutellaria baicalensis were successfully localized and visualized. CONCLUSIONS MALDI-MSI offers a favorable approach for investigating the spatial distribution and effective utilization of metabolites of Scutellaria baicalensis. The detailed spatial chemical information can not only improve our understanding of the biosynthesis pathways of flavonoid metabolites, but more importantly, suggest that we need to fully exert the overall medicinal value of Scutellaria baicalensis, strengthening the reuse and development of the resources of Scutellaria baicalensis aboveground parts.
Collapse
Affiliation(s)
- Peipei Zhou
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Lihua Zuo
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Chang Liu
- Department of Oral Emergency, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Baolin Xiong
- School of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou, China
| | - Zhuolun Li
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Xiaoguang Zhou
- Intelligene Biosystems (QingDao) Co. Ltd., Shangdong Province, China
| | - Heying Yue
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Qingquan Jia
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Tianyuan Zheng
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Jing Zou
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China
| | - Shuzhang Du
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China.
| | - Di Chen
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
| | - Zhi Sun
- Pharmaceutical Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Precision Clinical Pharmacy Laboratory of Henan Province, Zhengzhou, China.
| |
Collapse
|